Please Wait
Applying Filters...
menu
    • menu
    FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector 2025 highlights: FDA approves pill version of Novo’s Wegovy; BioMarin acquires Amicus for US$ 4.8 bn

    Stock Recap
    #PipelineProspector

    Menu

    Risedronic Acid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 990Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/01/2026 Polpharma
    Poland
    		 YuYu Pharmaceutical Co., Ltd. 20100226-121-G-15-07(7) risedronate sodium 2024-11-26 Pharmaceutical Works Polpharma S.A. Poland 19, Pelplinska Street., 83-200 Starogard Gdanski, Poland
    29/01/2026 Polpharma
    Poland
    		 Hwail Pharmaceutical Co., Ltd. 20100226-121-G-15-07(2) risedronate sodium 2011-06-15 Pharmaceutical Works polpharma SA@Hwail Pharmaceutical Co., Ltd. Poland 19, Pelplinska st 83-200 Starogard Gdanski, Poland@45 Balangongdan-ro 1-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.